Publications: Miss Mary Walker
López-Vicario C, Titos E, Walker ME, Alcaraz-Quiles J, Casulleras M, Durán-Güell M, Flores-Costa R, Pérez-Romero N et al.(2019).
Leukocytes from obese individuals exhibit an impaired SPM signature. FASEB journal : official publication of the Federation of American Societies for Experimental Biology
vol. 33,
(6)
7072-7083.
Laguna-Fernandez A, Checa A, Carracedo M, Artiach G, Petri MH, Baumgartner R, Forteza MJ, Jiang X et al.(2018).
ERV1/ChemR23 Signaling Protects Against Atherosclerosis by Modifying Oxidized Low-Density Lipoprotein Uptake and Phagocytosis in Macrophages. Circulation
vol. 138,
(16)
1693-1705.
Colas RA, Souza PR, Walker ME, Burton M, Zas¿ona Z, Curtis AM, Marques RM, Dalli J(2018).
Impaired production and diurnal regulation of vascular RvD <inf>n-3 DPA</inf> increase systemic inflammation and cardiovascular disease. Circulation Research
vol. 122,
(6)
855-863.
Dalli J, Colas RA, Walker ME, Serhan CN(2018).
Lipid Mediator Metabolomics Via LC-MS/MS Profiling and Analysis. Methods Mol Biol
vol. 1730,
59-72.
Walker ME, Souza PR, Colas RA, Dalli J(2017).
13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis. FASEB Journal
vol. 31,
(8)
3636-3648.
Primdahl KG, Aursnes M, Walker ME, Colas RA, Serhan CN, Dalli J, Hansen TV, Vik A(2016).
Synthesis of 13(R)-Hydroxy-7Z,10Z,13R,14E,16Z,19Z Docosapentaenoic Acid (13R-HDPA) and Its Biosynthetic Conversion to the 13-Series Resolvins. J Nat Prod
vol. 79,
(10)
2693-2702.
